Home530239 • BOM
Suven Life Sciences Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 16.10M | -34.31% |
Operating expense | 423.49M | -15.72% |
Net income | -391.17M | 6.34% |
Net profit margin | -2.43K | -42.58% |
Earnings per share | — | — |
EBITDA | -392.92M | 15.22% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.66B | -11.63% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 1.93B | — |
Shares outstanding | 218.53M | — |
Price to book | 14.90 | — |
Return on assets | — | — |
Return on capital | -52.79% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -391.17M | 6.34% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
₹131.25
Day range
₹128.15 - ₹141.00
Year range
₹83.27 - ₹169.00
Market cap
28.11B INR
Avg Volume
31.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
About
Founded
1989
Website
Employees
141
